About the Authors

Timothy A Chan, Sabine Glockner, Joo Mi Yi, Wei Chen, James G Herman, Kornel E Schuebel, Nita Ahuja, Stephen B Baylin
Cancer Biology Program, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America

Timothy A Chan
Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America

Sabine Glockner, Nita Ahuja
Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, United States of America

Wei Chen, Stephen B Baylin
Predoctoral Training Program in Human Genetics, The Johns Hopkins University, Baltimore, Maryland, United States of America

Leander Van Neste
Department of Molecular Biotechnology, Ghent University, Ghent, Belgium

Leslie Cope
Biometry and Clinical Trials Division, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America

Victor Velculescu
Ludwig Center for Cancer Genetics and Therapeutics, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America

Victor Velculescu
Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America

Corresponding Authors

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

TAC and SBB designed the study. TAC and SG performed the experiments for the study. TAC, VV, KES, and SBB analyzed the data and interpreted the results. TAC, WC, LVN, LC, and JGH contributed bioinformatics and statistical analysis to the research effort. TAC and SBB wrote the manuscript. NA enrolled patients and helped analyze the clinical outcomes data. JMY performed a portion of the bisulfite sequencing analysis of the common target.